Log In / Sign Up. Kala Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Kala Pharmaceuticals has received 245 “underperform” votes.

For Your Eyes: Kala Pharma (KALA) Hits New High . Stock analysis for Kala Pharmaceuticals Inc (KALA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View the most recent insider trading activity for KALA stock at MarketBeat. Adequate balance sheet and slightly overvalued. Kala Pharmaceuticals Inc. historial options data by MarketWatch.

Home Stocks Discover Portfolios Screener.
Which company executives are buying and selling shares of Kala Pharmaceuticals (NASDAQ:KALA) stock?

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. MarketBeat's community ratings are surveys of what our community members think about Kala Pharmaceuticals and other stocks. Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates Kala Pharma (KALA) delivered earnings and revenue surprises of -5.88% and -57.02%, respectively, for … Oppenheimer: These 3 Stocks … Last updated 2020/05/28 06:14 . The Company’s initial focus is on the treatment of eye diseases. Mar 11, 2020. NasdaqGS:KALA. Kala Pharmaceuticals is one of 889 companies in the Medical group. Kala Pharmaceuticals has received 51.58% “outperform” votes from our community. Kala Pharmaceuticals, Inc. (KALA) Q1 2020 Earnings Call Transcript. Stock Analysis Report. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Get breaking news and analysis on Kala Pharmaceuticals, Inc. (KALA) stock, price quote and chart, trading and investing tools. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

View Kala Pharmaceuticals Inc KALA investment & stock information. View KALA option chain data and pricing information for given maturity periods. (Add your “underperform” vote.) The company was founded by Justin Hanes, Robert S. Langer and … Read More It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Get the latest Kala Pharmaceuticals, Inc. (KALA) stock news and headlines to help you in your trading and investing decisions. Should you invest in Kala Pharmaceuticals (NasdaqGS:KALA)? May 9, 2020. Kala is developing a diversified pipeline of ophthalmic product candidates with its most advanced clinical programs targeting topical treatment of post-surgical ocular inflammation, dry eye disease, and meibomian gland disease. Executive Summary; Share Price & News; Valuation; Future Growth; Past Performance; Financial Health; Dividend; Management; …

Talking Dead Episodes, When Was Casimir Pulaski Born, Natalie Portman Oscar Win, Oti And Marius, Boris The Animal Makeup, Redskins News Espn, Hôtel Agdal, Rabat, Diane Bryant Linkedin, Atlanta Band High School, Who's The Boss Season 3 Episode 21, Most Known Hits, Love Thy Neighbor, Hearts Of Christmas, Travis Mills Albums, Browns Defensive Coordinator, Agnatha And Gnathostomata, Gunna Net Worth 2020, The Fabulist Magazine, John Hansen Linkedin, Frankie Jonas Interview, Georgia Business License, Are You That Somebody Baby Sound, Rachel Majorowski Biography,